Knowledge, Attitude and Practice Related to Chemotherapy Among Cancer Patients.
Muzna Suhail, Fabeha Saulat, Hira Khurram...
https://pubmed.ncbi.nlm.nih.gov/38616652/Actively Recruiting
Led by Dena h. Al-Tameemi · Updated on 2026-06-12
130
Participants Needed
1
Research Sites
13 weeks
Total Duration
Researchers are evaluating an Arabic-language mobile application using artificial intelligence AI to support women with breast cancer during chemotherapy. This trial aims to see if the app can provide safe and accurate advice, reduce treatment-related symptoms and side effects, improve medication adherence, and increase participants understanding and satisfaction with their treatment information. The study compares the AI app plus usual care to usual care alone in a randomized controlled design. Participants in the experimental group will use the AI-based mobile app daily for 12 weeks while receiving chemotherapy. The app offers personalized support including medication reminders, symptom monitoring, and educational guidance using natural language processing tailored to Iraqi patients. All AI-generated recommendations are reviewed by oncologists and pharmacists for safety. The control group will receive standard oncology care without access to the app but will complete the same assessments. Participants will complete short questionnaires about symptoms, medication adherence, quality of life, and treatment knowledge at the start, midpoint, and end of the 12-week study. Researchers will monitor app usage, user satisfaction, and compare AI advice accuracy with oncologist assessments. The study also aims to identify any technical or ethical challenges using the app. Participation includes routine follow-up visits and reporting any problems or feedback about the app, with total involvement lasting approximately 12 weeks.
CONDITIONS
Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients
D
Dena A. Al-Tameemi, MSc.
S
Samer Imad Mohammed, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Dena h. Al-Tameemi
Lead Sponsor
Baghdad Medical City
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 12 weeks
Participants in the experimental group will use the AI-based mobile app daily for 12 weeks alongside their chemotherapy. Those in the control group will receive usual oncology care without the app. Both groups complete questionnaires and report symptoms during this period.
Regular follow-up visits during chemotherapy cycles
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Muzna Suhail, Fabeha Saulat, Hira Khurram...
https://pubmed.ncbi.nlm.nih.gov/38616652/Radwa Ahmed Batran, Sara Tahoun, Lama Helmy...
https://pubmed.ncbi.nlm.nih.gov/40669034/Zainab Nazar Hasan Anber, Basil Oied Mohammed Saleh, Safana Ali Al-Rawi
https://pubmed.ncbi.nlm.nih.gov/31406940/Seema Yelne, Minakshi Chaudhary, Karishma Dod...
https://pubmed.ncbi.nlm.nih.gov/38143615/Mostafa Shaban, Yasmine M Osman, Nermen Abdelfatah Mohamed...
https://pubmed.ncbi.nlm.nih.gov/40731340/Dena h. Al-Tameemi
Lead Sponsor
Baghdad Medical City
Collaborating Sponsor